Basic research corroborated that the tangshenling mixture had a synergetic effect with benazepril through a different signaling pathway, which involved down regulation of atrial natriuretic factor (ANF) in plasma and glucose transporter 1 (GLUT1) in the kidney when treating DN [71]. The gene discussed is NPPA; the disease is liver dysplastic nodule.